Writing committees are charged with the task of performing an assessment of the evidence and acting as an independent group of authors to develop, update, or revise written recommendations for clinical practice.Įxperts in the subject under consideration are selected from both organizations to examine subject-specific data and write guidelines. The ACC/AHA Task Force on Practice Guidelines (Task Force), whose charge is to develop, update, or revise practice guidelines for cardiovascular diseases and procedures, directs this effort. The American College of Cardiology (ACC) and the American Heart Association (AHA) have jointly engaged in the production of guidelines in the area of cardiovascular disease since 1980. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist clinicians in selecting the best management strategy for an individual patient. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. Initial Clinical Evaluation in Patients With AF 2104 Reviewer Relationships With Industry and Other Entities (Relevant) 2097Īppendix 3. Author Relationships With Industry and Other Entities (Relevant) 2095Īppendix 2.
Postoperative Cardiac and Thoracic Surgery 2089Įvidence Gaps and Future Research Directions 2089Īppendix 1. Wolff-Parkinson-White and Pre-Excitation Syndromes 2086Ħ.8. AF Complicating Acute Coronary Syndromes 2086Ħ.5. Specific Patient Groups and AF: Recommendations 2086Ħ.2. AF Catheter Ablation to Maintain Sinus Rhythm 2085 Antiarrhythmic Drugs to Maintain Sinus Rhythm 2082ĥ.6. Cardiac Surgery-Left Atrial Appendage Occlusion/Excision: Recommendation 2079ĥ.4. Considerations in Selecting Anticoagulants 2079ģ.4. Risk Stratification Schemes (CHADS 2 and CHA 2DS 2-VASc) 2079ģ.3. Risk-Based Antithrombotic Therapy: Recommendations 2077ģ.2. Clinical Evaluation: Recommendation 2077ģ.1. Risk Factors and Associated Heart Disease 2076Ģ.4. Mechanisms of AF and Pathophysiology 2076Ģ.3. Organization of the Writing Committee 2074Ĭlinical Characteristics and Evaluation of AF 2076Ģ.2. Customer Service and Ordering Informationġ.1.Stroke: Vascular and Interventional Neurology.Journal of the American Heart Association (JAHA).Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).
0 kommentar(er)
